Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,611 | 55,070 | 36,344 | 38,043 | 28,706 |
| Marketable Securities | 60,335 | 53,461 | 59,068 | 71,332 | 94,852 |
| Receivables | 4,318 | 2,827 | 3,682 | 2,975 | 3,655 |
| TOTAL | $93,563 | $112,575 | $101,566 | $113,259 | $128,617 |
| Non-Current Assets | |||||
| PPE Net | 14,344 | 14,725 | 15,203 | 15,488 | 14,824 |
| Intangibles | 3,015 | 3,111 | 3,207 | 3,303 | 3,399 |
| Other Non-Current Assets | 1,790 | 1,790 | 1,790 | 1,802 | 1,802 |
| TOTAL | $19,149 | $19,626 | $20,200 | $20,593 | $20,025 |
| Total Assets | $112,712 | $132,201 | $121,766 | $133,852 | $148,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 17 | 143 | 267 | 505 |
| Accounts payable and accrued liabilities | 3,919 | 5,578 | 3,834 | 2,485 | 3,728 |
| Accrued Expenses | 5,217 | 6,744 | 4,898 | 4,593 | 4,075 |
| Other current liabilities | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| TOTAL | $16,197 | $19,092 | $15,583 | $14,009 | $14,929 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,220 | 2,220 | 2,226 | 2,232 | 2,238 |
| Other Non-Current Liabilities | 102 | 119 | 0 | 0 | 0 |
| TOTAL | $12,133 | $13,604 | $14,789 | $15,988 | $17,168 |
| Total Liabilities | $28,330 | $32,696 | $30,372 | $29,997 | $32,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,889 | 39,885 | 36,922 | 36,827 | 36,789 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -274,942 | -257,037 | -238,668 | -222,709 | -207,738 |
| Other shareholders' equity | 281 | 414 | 121 | 84 | 502 |
| TOTAL | $84,382 | $99,505 | $91,394 | $103,855 | $116,545 |
| Total Liabilities And Equity | $112,712 | $132,201 | $121,766 | $133,852 | $148,642 |